Lamya S. ShihabuddinMSc, PhD
Dr. Lamya S Shihabuddin, is the cluster head of rare neuro- diseases within the Neuroscience Research Therapeutic Area at Sanofi. Dr. Shihabuddin holds an MSc in Neurophysiology from American University of Beirut and Ph.D. in Neuroscience from the University of Miami. She trained as a postdoctoral fellow at The Salk Institute for Biological Studies in La Jolla, where she performed research on the generation of adult derived neural stem cells and potential use for neurodegenerative diseases and spinal cord injury. Dr. Shihabuddin joined Genzyme Corporation in 2000 to work on cell therapies for lysosomal storage diseases and other discovery projects in neurodegenerative diseases.
Since 2006, she has managed the Neuroscience efforts, focusing on rare diseases, at Genzyme Corporation. After becoming part of Sanofi in 2012, Dr. Shihabuddin continues to lead and provide oversight for research efforts focusing on genetically linked and rare neurological diseases.
The efforts of the group are focused on using various therapeutic platforms including small molecule, gene and RNAi therapies for treating rare neurologic diseases including, Amyotrophic lateral sclerosis, Huntington’s disease, Parkinson’s disease, and Rett Syndrome. Dr. Shihabuddin has authored more than 60 scientific articles and book chapters and is a co-author of several patents. She is a member of Society for Neuroscience, Movement Disorder Society, and American Society for Neural transplantation.